Note: Ingredients listed on restricted chemical lists
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
EC/CAS
532-32-1
Name of the chemical
Benzoic acid and its sodium salt
Concentration
N/A
General Information
Revision date
2021-06-18
Product name
RETROVIR SYRUP
Product Synonyms
RETROVIR SYRUP 50 MG/5 ML * RETROVIR/AZT ORAL SOLUTION 10 MG/ML * RETROVIR
Icons in SDS
Company Information
company name
ViiV Healthcare Limited
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Germ cell mutagenicity Category 2 Carcinogenicity Category 2
Environmental hazards
Not classified. Label elements, including precautionary statements Hazard symbol(s)
Signal word
Warning
Hazard statements
Suspected of causing genetic defects. Suspected of causing cancer.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Use personal protective equipment as required.
Response
IF exposed or concerned: Get medical advice/attention.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
1 % of the mixture consists of component(s) of unknown acute dermal toxicity. 64 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 11 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 11 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
